A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. This phase I/II trial is studying the side effects and best dose of
ixabepilone and how well it works in treating patients with recurrent glioma.